Baugh & Associates, LLC
- SEC CIK
- 0001730818
- Latest filing
- Jul 10, 2026
PFE holding history
Pfizer Inc in every 13F filed by Baugh & Associates, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 208,631
- Value
- $5.02M
- % of portfolio
- 2.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 208,631 | $5.02M | 2.2% | −16,386−7.3% | Reduced | Holders |
| Q1 2026 | 225,017 | $6.32M | 2.7% | +12,727+6.0% | Added | Holders |
| Q4 2025 | 212,290 | $4.88M | 2.4% | +34,733+19.6% | Added | Holders |
| Q3 2025 | 177,557 | $4.20M | 2.1% | −6,802−3.7% | Reduced | Holders |
| Q2 2025 | 184,359 | $4.17M | 2.2% | −10,292−5.3% | Reduced | Holders |
| Q1 2025 | 194,651 | $4.71M | 2.4% | +483+0.2% | Added | Holders |
| Q4 2024 | 194,168 | $4.97M | 2.6% | +29,025+17.6% | Added | Holders |
| Q3 2024 | 165,143 | $4.60M | 2.4% | +997+0.6% | Added | Holders |
| Q2 2024 | 164,146 | $4.79M | 2.5% | −7,360−4.3% | Reduced | Holders |
| Q1 2024 | 171,506 | $4.76M | 2.5% | +43,907+34.4% | Added | Holders |
| Q4 2023 | 127,599 | $3.67M | 2.1% | −5,813−4.4% | Reduced | Holders |
| Q3 2023 | 133,412 | $4.43M | 2.8% | +19,323+16.9% | Added | Holders |
| Q2 2023 | 114,089 | $4.18M | 2.5% | +1,890+1.7% | Added | Holders |
| Q1 2023 | 112,199 | $4.66M | 3.0% | −2,270−2.0% | Reduced | Holders |
| Q4 2022 | 114,469 | $5.87M | 3.8% | −120−0.1% | Reduced | Holders |
| Q3 2022 | 114,589 | $5.01M | 3.5% | +1,538+1.4% | Added | Holders |
| Q2 2022 | 113,051 | $5.93M | 4.0% | −1,189−1.0% | Reduced | Holders |
| Q1 2022 | 114,240 | $5.91M | 3.5% | −355−0.3% | Reduced | Holders |
| Q4 2021 | 114,595 | $6.77M | 3.7% | −85−0.1% | Reduced | Holders |
| Q3 2021 | 114,680 | $4.93M | 3.0% | −187−0.2% | Reduced | Holders |
| Q2 2021 | 114,867 | $4.50M | 2.8% | −1,000−0.9% | Reduced | Holders |
| Q1 2021 | 115,867 | $4.20M | 2.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.